Laura Q.M. Chow
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 82
- CAR-T cell therapy research 22
- Colorectal Cancer Treatments and Studies 22
- Lung Cancer Research Studies 19
- HER2/EGFR in Cancer Research 14
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies 18
- Immunology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations 60
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 17
- Co-authors
- S. Gail EckhardtJonathan D. ChengRaanan BergerScott GettingerTanguy Y. SeiwertHossein BorghaeiJared LuncefordNaiyer A. Rizvi
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (57 papers)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Laura Q.M. Chow
156 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 9.1k
- Otorhinolaryngology 1.2k
- Immunology 3.0k
- Pulmonary and Respiratory Medicine 4.6k
- Cancer Research 1.6k
Countries citing papers authored by Laura Q.M. Chow
This map shows the geographic impact of Laura Q.M. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Q.M. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Q.M. Chow more than expected).
Fields of papers citing papers by Laura Q.M. Chow
This network shows the impact of papers produced by Laura Q.M. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Q.M. Chow. The network helps show where Laura Q.M. Chow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Q.M. Chow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 54 | |
| 4 | 2021 | 15 | |
| 5 | 2021 | 10 | |
| 6 | 2019 | 135 | |
| 7 | 2018 | 79 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 114 | |
| 10 | 2018 | 150 | |
| 11 | PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancerbreakdown → | 2017 | 453 |
| 12 | 2017 | 183 | |
| 13 | 2017 | 22 | |
| 14 | 2016 | 5 | |
| 15 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialbreakdown → | 2016 | 1275 |
| 16 | 2016 | 8 | |
| 17 | 2015 | 182 | |
| 18 | 2015 | 54 | |
| 19 | 2013 | 24 | |
| 20 | 2007 | 22 |
About Laura Q.M. Chow
Laura Q.M. Chow is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 159 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (82 papers), Lung Cancer Treatments and Mutations (60 papers), CAR-T cell therapy research (22 papers), Colorectal Cancer Treatments and Studies (22 papers), Lung Cancer Research Studies (19 papers), Head and Neck Cancer Studies (18 papers), Cancer Genomics and Diagnostics (17 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Oncology (9.1k citations), Otorhinolaryngology (1.2k citations) and Immunology (3.0k citations). Laura Q.M. Chow has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include S. Gail Eckhardt, Jonathan D. Cheng, Raanan Berger, Scott Gettinger, Tanguy Y. Seiwert, Hossein Borghaei, Jared Lunceford, Naiyer A. Rizvi, Scott Antonia and Julie R. Brahmer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.